​

Funding Round

Series A - Adcentrx Therapeutics

Series A - Adcentrx Therapeutics

Investment Firm

Overview

Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases

Announced Date

Apr 28, 2021

Closed on Date

Apr 28, 2021

Funding Type

Series A

Highlights

Location

United States, North America

Social

Investor Lead

C-Bridge Capital

C-Bridge Capital

C-Bridge Capital is a debt and early_stage_venture and late_stage_venture and private_equity and venture firm.

Participant Investors

3

Investor Name
Participant InvestorCBC Group
Participant InvestorZoo Capital
Participant InvestorC-Bridge Capital

Round Details and Background

Adcentrx Therapeutics raised $50000000 on 2021-04-28 in Series A

Adcentrx is a biotechnology company focused on therapeutic development for cancer and other life-threatening diseases

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Apr 24, 2023
Series A - Adcentrx Therapeutics
8-51.0M
Apr 28, 2021
Series A - Adcentrx Therapeutics
3-50.0M

Recent Activity

There is no recent news or activity for this profile.